Skin Cancer section

Skin Cancer News & Features

Macrophages may play critical role in melanoma resistance to BRAF inhibitors

Investigators have discovered one way in which melanoma becomes resistant to a particular form of targeted therapy, a discovery that may lead to a new melanoma target or prompt new designs for treatment.

Periocular basal cell carcinomas exhibit fast growth rates

Periocular basal cell carcinomas exhibit fast growth rates

Faster growth rate for basal cell carcinomas is seen in association with recurrent tumors, larger tumors at presentation, and male sex.

Triple combination of two targeted therapies + immunotherapy is more effective in advanced melanoma

A new triple combination therapy has shown signs that it can more effectively control advanced melanoma that previous, dual-therapy combinations.

Survival rates are lower for patients with high-risk melanoma with mutations

Survival rates are lower for patients with high-risk melanoma with mutations

No statistical difference was seen in 5-year survival for melanoma patients with NRAS or BRAF mutations.

Time from melanoma diagnosis to surgery is commonly delayed in Medicare patients

Time from melanoma diagnosis to surgery is commonly delayed in Medicare patients

Surgery is delayed in 1 in 5 Medicare patients with melanoma.

April Contest

Click here to get started

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs